Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice

Fig. 5

HUCMSC-MVs transplantation in POI mice. a The schedule of CTX/BUS administration and treatment with PBS or HUCMSC-MVs. b HE staining of the ovarian section 28 days after MVs transplantation. Scale bars = 100 μm. c The follicle number and proportion of atretic follicles in the three groups (*P < 0.05 vs the control group, #P < 0.05 vs the POI-MVs group)

Back to article page